Nuvalent (NUVL) Payables (2020 - 2026)
Nuvalent (NUVL) posted Payables of $22.1 million for Q1 2026, down 26.6% on a QoQ basis from $30.2 million in Q4 2025, and down 15.4% year-over-year from $26.2 million in Q1 2025.
Nuvalent (NUVL) Payables (2020 - 2026) Analysis & Trends
Nuvalent's Payables history runs 7 years deep, the most recent figure standing at $22.1 million for Q1 2026.
- Quarterly Payables fell 15.4% year-over-year to $22.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.1 million (down 15.4% YoY) and the FY2025 annual result came in at $30.2 million, up 477.19% from the prior year.
- Payables was $22.1 million for Q1 2026 at Nuvalent, down from $30.2 million in the prior quarter.
- Across five years, Payables topped out at $30.2 million in Q4 2025 and bottomed at $4.0 million in Q2 2022.
- A 5-year average of $12.3 million and a median of $9.3 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables tumbled 43.66% — and 2025, when it surged 477.19%.
- Nuvalent's Payables stood at $7.2 million in 2022, then climbed by 28.9% to $9.3 million in 2023, then slumped by 43.66% to $5.2 million in 2024, then jumped by 477.19% to $30.2 million in 2025, then decreased by 26.6% to $22.1 million in 2026.
- Business Quant data shows NUVL's Payables at $22.1 million in Q1 2026, $30.2 million in Q4 2025, and $22.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 22.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.14 Mn |
| Dec 31, 2025 | 30.16 Mn |
| Sep 30, 2025 | 22.01 Mn |
| Jun 30, 2025 | 13.34 Mn |
| Mar 31, 2025 | 26.17 Mn |
| Dec 31, 2024 | 5.23 Mn |
| Sep 30, 2024 | 15.93 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Mar 31, 2024 | 13.40 Mn |
| Dec 31, 2023 | 9.27 Mn |
| Sep 30, 2023 | 9.78 Mn |
| Jun 30, 2023 | 8.12 Mn |
| Mar 31, 2023 | 6.43 Mn |
| Dec 31, 2022 | 7.20 Mn |
| Sep 30, 2022 | 4.62 Mn |
| Jun 30, 2022 | 4.03 Mn |
| Mar 31, 2022 | 4.25 Mn |
| Dec 31, 2021 | 2.89 Mn |
| Sep 30, 2021 | 2.53 Mn |
| Jun 30, 2021 | 3.80 Mn |